ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 756468 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 756468; 2) Community: the network communities that were significantly associated with the response to NSC 756468; 3) Molecule: the relationships between components within communities and NSC 756468; 4) MDR: the compounds that were significantly associated with the NSC 756468.

NSC Compound Enrichment Correlation
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0141354818755237 0.17516621
NSC 12198 Dromostanolone Propionate 0.0141354818755239 0.19653526
NSC 12455 Acid Alizarin Red B 0.0141354818755239 0.23672874
NSC 128571 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) 0.0141354818755239 0.34400174
NSC 149286 1,4-Pentadien-3-one, 1,5-di-3-pyridyl- 0.0141354818755239 0.31231256
NSC 169774 Bromocriptine methanesulfonate 0.0141354818755239 0.27696499
NSC 237020 TA 1067 0.0141354818755239 0.46808017
NSC 290193 CYCLOSPORIN A 0.0141354818755239 0.34710063
NSC 324368 3,5,9-Trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-7-methoxy-N,N,N-trimethyl-, hydroxide, inner salt, 4-oxide 0.0141354818755239 0.11419041
NSC 335766 Quinazoline, 4-ethyl-6-methoxy-7-(oxiranylmethoxy)- 0.0141354818755239 0.24486937
Total:120  Current:44    [First] [Prev] [Next] [Last]